Geoffrey James Obeney
CIK 1426595 · View on SEC EDGAR ↗
First SEC filing: March 19, 2010 · Latest: March 19, 2010
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 9, 2011 | CREX | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 17, 2010 | CREX | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 17, 2008 | CREX | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 31, 2008 | CREX | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 9, 2011 | CREX | Stock Option (right to buy) [F1] | Common Stock (20,000) | $1.17 | March 23, 2021 | 20,000 | Acquired |
| March 17, 2010 | CREX | Stock Option (right to buy) [F1] | Common Stock (20,000) | $2.45 | March 17, 2020 | 20,000 | Acquired |
| Oct. 17, 2008 | CREX | Stock Option (right to buy) [F1] | Common Stock (20,000) | $1.61 | Oct. 17, 2013 | 20,000 | Acquired |
| March 31, 2008 | CREX | Stock Option (right to buy) [F1] | Common Stock (40,000) | $4.00 | March 31, 2013 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).